Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bladder Capacity as an Objective Measure of Response to Intravesical Treatment of Newly Diagnosed Interstitial Cystitis: a Prospective, Randomized Trial

NCT05223244 is registered in ClinicalTrials.gov with Endeavor Health as lead sponsor.

NCT NCT05223244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05223244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bladder Capacity as an Objective Measure of Response to Intravesical Treatment of Newly Diagnosed Interstitial Cystitis: a Prospective, Randomized Trial
Lead sponsor
Endeavor Health
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2011
Completion date
March 30, 2020
Enrollment
83 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial cystitis, painful bladder syndrome